Literature DB >> 26843889

EBV glycoproteins: where are we now?

Lindsey M Hutt-Fletcher1.   

Abstract

Glycoproteins are critical to virus entry, to spread within and between hosts and can modify the behavior of cells. Many viruses carry only a few, most found in the virion envelope. EBV makes more than 12, providing flexibility in how it colonizes its human host. Some are dedicated to getting the virus through the cell membrane and on toward the nucleus of the cell, some help guide the virus back out and on to the next cell in the same or a new host. Yet others undermine host defenses helping the virus persist for a lifetime, maintaining a presence that is mostly tolerated and serves to perpetuate EBV as one of the most common infections of man.

Entities:  

Keywords:  B cells; assembly; attachment; egress; epithelial cells; fusion; immune evasion

Year:  2015        PMID: 26843889      PMCID: PMC4734392          DOI: 10.2217/fvl.15.80

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  65 in total

1.  Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.

Authors:  C M Borza; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

3.  The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase.

Authors:  Patrick S Beisser; Dennis Verzijl; Yvonne K Gruijthuijsen; Erik Beuken; Martine J Smit; Rob Leurs; Cathrien A Bruggeman; Cornelis Vink
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.

Authors:  Ru Jiang; Xin Gu; Tara N Moore-Medlin; Cherie-Ann Nathan; Lindsey M Hutt-Fletcher
Journal:  Oral Oncol       Date:  2012-04-16       Impact factor: 5.337

5.  EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

6.  The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2007-10-22       Impact factor: 3.616

7.  Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B.

Authors:  Marija Backovic; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 8.  Epstein-barr virus vaccines.

Authors:  Jeffrey I Cohen
Journal:  Clin Transl Immunology       Date:  2015-01-23

9.  The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.

Authors:  Jianmin Zuo; Andrew Currin; Bryan D Griffin; Claire Shannon-Lowe; Wendy A Thomas; Maaike E Ressing; Emmanuel J H J Wiertz; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

10.  A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread.

Authors:  Michael B Gill; Rachel Edgar; Janet S May; Philip G Stevenson
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more
  16 in total

1.  Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Authors:  Zhiwei Liu; Anna E Coghill; Ruth M Pfeiffer; Carla Proietti; Wan-Lun Hsu; Yin-Chu Chien; Lea Lekieffre; Lutz Krause; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Jason Mulvenna; Jaap M Middeldorp; Jeff Bethony; Chien-Jen Chen; Denise L Doolan; Allan Hildesheim
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

2.  Prediction of MicroRNAs in the Epstein-Barr Virus Reveals Potential Targets for the Viral Self-Regulation.

Authors:  Victor Serrano-Solis; Angelica Cardoso Carlos; Vinicius Maracaja-Coutinho; Sávio Torres de Farias
Journal:  Indian J Microbiol       Date:  2018-12-28       Impact factor: 2.461

3.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

Authors:  Junping Hong; Ling Zhong; Qingbing Zheng; Qian Wu; Zhenghui Zha; Dongmei Wei; Haiwen Chen; Wanlin Zhang; Shanshan Zhang; Yang Huang; Kaiyun Chen; Junyu Chen; Shaowei Li; Mu-Sheng Zeng; Yi-Xin Zeng; Ningshao Xia; Xiao Zhang; Miao Xu; Yixin Chen
Journal:  J Virol       Date:  2022-03-29       Impact factor: 6.549

5.  Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins.

Authors:  Karthik Sathiyamoorthy; Yao Xiong Hu; Britta S Möhl; Jia Chen; Richard Longnecker; Theodore S Jardetzky
Journal:  Nat Commun       Date:  2016-12-08       Impact factor: 14.919

Review 6.  Epstein-Barr Virus and Systemic Autoimmune Diseases.

Authors:  Gunnar Houen; Nicole Hartwig Trier
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

7.  Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.

Authors:  Julio Alonso-Padilla; Esther M Lafuente; Pedro A Reche
Journal:  J Immunol Res       Date:  2017-09-28       Impact factor: 4.818

8.  A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells.

Authors:  Ina Ersing; Luis Nobre; Liang Wei Wang; Lior Soday; Yijie Ma; Joao A Paulo; Yohei Narita; Camille W Ashbaugh; Chang Jiang; Nicholas E Grayson; Elliott Kieff; Steven P Gygi; Michael P Weekes; Benjamin E Gewurz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

9.  A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits.

Authors:  Gabriela M Escalante; Joslyn Foley; Lorraine Z Mutsvunguma; Esther Rodriguez; David H Mulama; Murali Muniraju; Peng Ye; Anne K Barasa; Javier Gordon Ogembo
Journal:  Vaccines (Basel)       Date:  2020-04-06

10.  A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection.

Authors:  Xiao Zhang; Bingchun Zhao; Mingmei Ding; Shuo Song; Yinfeng Kang; Yang Yu; Miao Xu; Tong Xiang; Ling Gao; Qisheng Feng; Qinjian Zhao; Mu-Sheng Zeng; Claude Krummenacher; Yi-Xin Zeng
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.